Exelixis Inc reports results for the quarter ended in September 30 - Earnings Summary

Exelixis

30/10/2024 04:10

* Exelixis Inc  EXEL.OQ  reported quarterly adjusted
earnings of
40 cents​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported
breakeven earnings per share.  The mean expectation of
twenty analysts for the quarter was for earnings of 35 cents per
share. Wall Street expected results to range from 31 cents to 37
cents per share.
    * Revenue rose 14.3% to $539.54 million from a year ago;
analysts
expected $490.02 million. 
    * Exelixis Inc's reported EPS for the quarter was 40 cents​.
    * The company reported quarterly net income of $117.97
million.
    * Exelixis Inc shares had risen by 9.8% this quarter and
gained 18.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 6.2%
in the last three months.​ 
    * In the last 30 days, two analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 14 "strong buy" or "buy," 6
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Exelixis Inc is
32.00 
This summary was machine generated from LSEG data October 30 at
04:10 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.35           0.40           Beat
 Jun. 30 2024      0.30           0.77           Beat
 Mar. 31 2024      0.24           0.20           Missed
 Dec. 31 2023      0.21           0.27           Beat